BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 110628
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.110628
Table 3 Predictors of left ventricular hypertrophy, n (%)/mean ± SD
VariablesUnivariate analysis
Multivariate analysis
LVH
No LVH
P value
OR (95%CI)
P value
Age0.28
18-50 years49 (33)100 (67)
> 50 years43 (39)66 (61)
Gender0.0042.51 (1.17-5.41)0.02
Male76 (42)91 (58)
Female25 (25)75 (75)
Obesity29 (33)60 (67)0.49
BMI ranges0.78
< 2546 (38)76 (62)
25-3025 (33)51 (67)
> 3021 (35)39 (65)
PH34 (52)58 (30)0.0022.07 (1.11-3.86)0.02
Mitral regurgitation (grade 2-4)49 (39)33 (35)0.56
Tricuspid regurgitation33 (37)59 (36)0.89
Aortic regurgitation18 (40)74 (35)0.61
LVSD17 (55)14 (45)0.0162.11 (0.89-5.02)0.09
DD38 (54)33 (46)< 0.0012.47 (1.29-4.73)0.006
MR (grade 2-3)49 (39)77 (61)0.58
TR59 (36)107 (64)0.89
AR18 (40)27 (60)0.61
Hypertension91 (36)160 (64)0.43
Pericardial effusion18 (44)33 (56)0.24
Dyslipidemia46 (48)50 (52)0.0021.94 (1.07-3.53)0.03
Smoking 49 (40)72 (60)0.130.46 (0.36-1.58)0.46
Diabetes15 (44)19 (56)0.27
Impaired fasting glucose55 (42)75 (58)0.031.38 (0.76-2.50)0.30
Hyperuricemia27 (35)50 (65)0.90
Duration of dialysis in months22.23 ± 19.7123.00 ± 23.150.79
Total-cholesterol (mmol/L)
4.49 ± 1.274.36 ± 1.090.40
LDL cholesterol (mmol/L)2.93 ± 3.162.55 ± 0.90 0.26
HDL cholesterol (mmol/L)1.25 ± 0.501.23 ± 0.490.74
Triglyceride (mmol/L)1.72 ± 1.171.54 ± 1.120.23
Phosphate (mmol/L)1.54 ± 0.561.53 ± 0.570.88
PTH (pmol/L)22.68 ± 25.9529.52 ± 27.120.171.00 (0.98-1.02)0.79
Family history of coronary artery disease4 (20)16 (80)0.130.37 (0.11-1.30)0.12
Pre-emptive transplant6 (43) 8 (57)0.82
Hemodialysis74 (36)133 (64)
Peritoneal dialysis12 (33)24 (67)


Write to the Help Desk